Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/26947Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Zhuravlyova, Larysa | - |
| dc.contributor.author | Oliinyk, Mariia | - |
| dc.contributor.author | Sikalo, Yuliia | - |
| dc.date.accessioned | 2020-10-13T05:55:47Z | - |
| dc.date.available | 2020-10-13T05:55:47Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Sikalo Y. Relationship between melatonin serum levels and the efficacy of selective serotonin reuptake inhibitor paroxetine in patients with rheumatoid arthritis / Y. Sikalo, L. Zhuravlyova, M. Oliinyk // Annals of the Rheumatic Diseases. – 2020. – Т. 79, suppl 1. – P. 645. | en_US |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/26947 | - |
| dc.description.abstract | Numerous clinical and epidemiological studies have established that there is a close relationship between inflammation, chronic pain and psycho-emotional disorders in rheumatoid arthritis. The common pathogenetic mechanism is manifested in the defect of melatonin mediation and cytokine stimulation. Therefore, features of the use of selective serotonin reuptake inhibitors is relevant. | en_US |
| dc.language.iso | en | en_US |
| dc.subject | rheumatoid arthritis | en_US |
| dc.subject | melatonin | en_US |
| dc.subject | selective serotonin reuptake inhibitor | en_US |
| dc.title | Relationship between melatonin serum levels and the efficacy of selective serotonin reuptake inhibitor paroxetine in patients with rheumatoid arthritis | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Наукові праці. Кафедра внутрішньої медицини № 3 та ендокринології | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| relationship between melatonin.pdf | 157,7 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.